Eli Lilly EVP & General Counsel Anat Hakim Sells $7.01M in Common Stock via 10b5-1 Plan
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Insider Sale Alert: Eli Lilly & Co ($LLY) Insider: Anat Hakim (EVP, GC & Secretary) Transaction Date: November 2, 2026 Shares Sold: 5,000 @ $1,402.52 Total Value: ~$7.01M Ownership Nature: Indirect (By spouse) Plan: Rule 10b5-1 (Adopted Feb 10, 2026) Post-Transaction Indirect Shares (Spouse): 4,137.456
Comprehensive Analysis
Insider Transaction Overview
On November 2, 2026, Anat Hakim, Executive Vice President, General Counsel, and Secretary of Eli Lilly & Co ($LLY), disposed of 5,000 shares of common stock at a price of $1,402.52 per share. The gross transaction value totaled approximately $7,012,600.
Transaction Structure & 10b5-1 Plan
- Trading Plan: The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 10, 2026. This pre-scheduled mechanism mitigates concerns regarding opportunistic trading or possession of material non-public information (MNPI).
- Ownership Details: The sold shares were held indirectly through the reporting person's spouse. Following the sale, 4,137.456 shares remain in the spouse's account.
Overall Holdings Post-Transaction
Following this transaction, Anat Hakim maintains significant equity exposure to Eli Lilly:
- Direct Ownership: 25,724.568 shares
- Indirect (Spouse): 4,137.456 shares
- Indirect (Anat Hakim SLAT): 15,700 shares
- Total Retained Position:
45,562 shares ($63.9M at current prices)
Market & Governance Implications
Because the sale was executed under a Rule 10b5-1 plan established nearly nine months prior and represents only a partial liquidation of family holdings (Hakim retains over 45,000 shares across direct and trust accounts), the transaction carries Medium significance and is typical of planned executive liquidity and diversification.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
